Literature DB >> 10447928

Interleukin-8, interleukin-10, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression levels are higher in synovial tissue from patients with rheumatoid arthritis than in osteoarthritis.

J Furuzawa-Carballeda1, J Alcocer-Varela.   

Abstract

The aim of this work was to determine differences in pro- and anti-inflammatory cytokine and adhesion molecule expression in synovial tissue from patients with rheumatoid arthritis (RA) or osteoarthritis (OA). Synovial tissue samples were obtained from patients with RA and OA, and from healthy individuals. The expression of mRNA of interleukin (IL)-1beta, IL-4, IL-6, IL-8, IL-10, IL-13, tumour necrosis factor-alpha (TNF-alpha) and transforming growth-factor-beta1 (TGF-beta1) was evaluated by the polymerase chain reaction (PCR). In addition, IL-8 and IL-10 transcripts were measured by quantitative PCR. The expression of IL-8 and IL-10 proteins was determined by immunoperoxidase staining. To evaluate the inflammatory stage of synovial tissue, vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) protein expression was also determined. RA patients were found to display higher levels of adhesion molecules than patients with OA. PCR analysis showed a similar profile of cytokine transcripts between the OA and RA groups. Gene expression of IL-4 and IL-13 in synovium was undetectable. In contrast, IL-1beta, IL-6, IL-8, IL-10, TNF-alpha and TGF-beta1 transcripts were expressed by both groups. Increased levels of IL-8 and IL-10 transcripts and their proteins were observed in synovium from RA patients when compared to patients with OA and healthy controls. Thus, our data show that IL-8, IL-10, ICAM-1 and VCAM-1 expression levels are higher in synovial tissue from patients with RA than in similar tissue from patients with OA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447928     DOI: 10.1046/j.1365-3083.1999.00573.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

Review 1.  The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis.

Authors:  Jérémie Sellam; Francis Berenbaum
Journal:  Nat Rev Rheumatol       Date:  2010-10-05       Impact factor: 20.543

Review 2.  Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease.

Authors:  Arnd Heiligenhaus; Stephan Thurau; Maren Hennig; Rafael S Grajewski; Gerhild Wildner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-25       Impact factor: 3.117

3.  Role of osteopontin in amplification and perpetuation of rheumatoid synovitis.

Authors:  Guangwu Xu; Hong Nie; Ningli Li; Wenxin Zheng; Dongqing Zhang; Guozhang Feng; Liqing Ni; Rong Xu; Jian Hong; Jingwu Z Zhang
Journal:  J Clin Invest       Date:  2005-03-03       Impact factor: 14.808

4.  Mediators of inflammation are down-regulated while apoptosis is up-regulated in rheumatoid arthritis synovial tissue by polymerized collagen.

Authors:  J Furuzawa-Carballeda; R Rodríquez-Calderón; L Díaz de León; J Alcocer-Varela
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

5.  Decrease in circulating endothelial cell adhesion molecule and thrombomodulin levels during oral iloprost treatment in rheumatoid arthritis patients: preliminary results.

Authors:  Michael W J Boehme; Ino K Gao; Cornelia Norden; Ernst-Martin Lemmel
Journal:  Rheumatol Int       Date:  2005-02-08       Impact factor: 2.631

6.  Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment.

Authors:  Will Foster; David Carruthers; Gregory Y H Lip; Andrew D Blann
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

7.  Effect of a small molecule inhibitor of nuclear factor-kappaB nuclear translocation in a murine model of arthritis and cultured human synovial cells.

Authors:  Kyoko Wakamatsu; Toshihiro Nanki; Nobuyuki Miyasaka; Kazuo Umezawa; Tetsuo Kubota
Journal:  Arthritis Res Ther       Date:  2005-09-30       Impact factor: 5.156

Review 8.  Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome.

Authors:  Mark C Bagley; Terence Davis; Paola G S Murziani; Caroline S Widdowson; David Kipling
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-04

9.  Injectable amnion hydrogel-mediated delivery of adipose-derived stem cells for osteoarthritis treatment.

Authors:  Maumita Bhattacharjee; Jorge L Escobar Ivirico; Ho-Man Kan; Shiv Shah; Takayoshi Otsuka; Rosalie Bordett; Mohammed Barajaa; Naveen Nagiah; Rishikesh Pandey; Lakshmi S Nair; Cato T Laurencin
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-25       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.